Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,398.00    8.00 (0.58%)
Bid:
1,394.00
Ask:
1,412.00
Spread: 18.00 (1.291%)
Market Cap: £850.76m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Kepler Trust Intelligence: New Research

5 Jun 2020 09:00

RNS Number : 1044P
ICG Enterprise Trust PLC
05 June 2020
 

ICG Enterprise: New research

05/06/2020

With its focus on defensive growth, ICGT's current discount feels unwarranted...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAXKSELNEEEA
Date   Source Headline
2nd Jun 20269:28 amBUSReducing management fee cap by 20% over two years to 1.00% of NAV
1st Jun 20267:00 amBUSVoting Rights and Capital
27th May 20267:00 amBUSTransaction in Own Shares
26th May 20267:00 amBUSTransaction in Own Shares
22nd May 20267:00 amBUSTransaction in Own Shares
21st May 20267:00 amBUSTransaction in Own Shares
20th May 20267:00 amBUSTransaction in Own Shares
19th May 20265:01 pmBUSAnnual Report and Accounts
19th May 20267:00 amBUSTransaction in Own Shares
18th May 20267:00 amBUSTransaction in Own Shares
15th May 20267:00 amBUSTransaction in Own Shares
14th May 20262:42 pmRNS-RQuotedData's In The HotSeat
14th May 20267:00 amBUSTransaction in Own Shares
12th May 20267:00 amBUSTransaction in Own Shares
11th May 20267:00 amBUSTransaction in Own Shares
7th May 20267:00 amBUSTransaction in Own Shares
7th May 20267:00 amBUSPreliminary Results for the twelve months ended 31 January 2026
5th May 20267:00 amBUSTransaction in Own Shares
1st May 20267:00 amBUSTransaction in Own Shares
1st May 20267:00 amBUSVoting Rights and Capital
27th Apr 20267:00 amBUSTransaction in Own Shares
24th Apr 20267:00 amBUSNotification of Share Transaction
21st Apr 20267:00 amBUSTransaction in Own Shares
20th Apr 20267:00 amBUSTransaction in Own Shares
17th Apr 20267:00 amBUSTransaction in Own Shares
16th Apr 20267:00 amBUSTransaction in Own Shares
15th Apr 20267:00 amBUSTransaction in Own Shares
7th Apr 20264:00 pmBUSDirector/PDMR Shareholding
2nd Apr 202612:34 pmBUSDirector/PDMR Shareholding
1st Apr 20267:00 amBUSVoting Rights and Capital
31st Mar 20267:00 amBUSTransaction in Own Shares
25th Mar 20267:00 amBUSTransaction in Own Shares
20th Mar 20267:00 amBUSTransaction in Own Shares
17th Mar 20261:34 pmBUSDirector/PDMR Shareholding
13th Mar 202612:45 pmRNS-RHardman & Co Research: Shareholder seminar 2026: resilience and growth
12th Mar 20267:00 amBUSDirector/PDMR Shareholding
4th Mar 20267:00 amBUSTransaction in Own Shares
2nd Mar 20267:00 amBUSTransaction in Own Shares
2nd Mar 20267:00 amBUSVoting Rights and Capital
27th Feb 20267:00 amGNWTransaction in Own Shares
26th Feb 20267:00 amGNWTransaction in Own Shares
25th Feb 20267:00 amGNWTransaction in Own Shares
24th Feb 20267:00 amGNWTransaction in Own Shares
23rd Feb 20267:00 amGNWTransaction in Own Shares
20th Feb 20267:00 amGNWTransaction in Own Shares
19th Feb 20267:00 amGNWTransaction in Own Shares
18th Feb 20267:00 amGNWTransaction in Own Shares
17th Feb 20267:00 amGNWTransaction in Own Shares
16th Feb 20267:00 amGNWTransaction in Own Shares
13th Feb 202611:43 amGNWTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.